Procyon Advisors’s CONMED CNMD Stock Holding History

Procyon Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-26	Closed	-$2K	–	362
2020 Q2	$2K	Hold	26	–	–	﹤0.01%	915
2020 Q1	$1K	Sell	26 -29	-53%	-$2.67K	﹤0.01%	900
2019 Q4	$6K	Buy	+55	New	+$5.86K	﹤0.01%	761

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Procyon Advisors's CNMD Position: Q3 2020 in Review

Procyon Advisors sold out of CONMED (CNMD) in Q3 2020, closing a stake of 26 shares — an estimated $2K sold.

Procyon Advisors first reported a position in CNMD in Q4 2019 and held it in 3 quarters. The position peaked at $6K in Q4 2019. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

Procyon Advisors reported no remaining CONMED position as of Q3 2020 after selling out during the quarter.
Procyon Advisors sold 26 CONMED shares in Q3 2020, an estimated $2K.
Procyon Advisors first reported a position in CONMED in Q4 2019 and held it in 3 quarters.
Procyon Advisors's CONMED position peaked at $6K in Q4 2019.
240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.